Fundraising Fox
/Companies
Sign in

OLI Technologies

North Brunswick, US · Founded 2021 · Delaware corporation · 9 employees on LinkedIn · 3 known investors

Find your way into OLI Technologies

Sign up to see every warm intro you have to OLI Technologies

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the OLI Technologies team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.

Digital HealthHardwareHealthtechMedical Devices

Founders & leadership

TWThomas Weindl
Thomas WeindlCEO & Co-FounderThomas spent six years at Johnson & Johnson MedTech, advancing from research chemist to senior research scientist and technical team leader, and previously worked as a research and engineering chemist at ExxonMobil and a research technician at Ingredion. He was an Entrepreneurial Lead in the NSF I-Corps program in 2021 and works between New Jersey and Chicago on medtech and hardtech.
RLRay Luo
Ray LuoCOO
LBLes Bogdanowicz
Les BogdanowiczCTOLes Bogdanowicz is CTO of OLI Technologies and holds a PhD in Bioengineering from the University of Illinois at Chicago, where he serves as adjunct faculty. He has led engineering, clinical project management, and regulatory affairs for multiple medical device companies, bringing over 20 devices to market, and holds patents in the field.

Board

CNCarl Nicholas Ng
Carl Nicholas NgBoard MemberGeneral Partner at Verge HealthTech Fund

Investors · 3

Verge HealthTech Fundlisted by Verge HealthTech FundSingapore · $500K – $1.5M

How we know: Verge HealthTech Fund's portfolio page · Not right? Tell us

BoxOne VenturesreportedMontréal · $500K

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$700K disclosed across 1 of 2 rounds · 2025–2026

▶$3MofferedSep 2026 · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas WeindlExecutive Officer, Director
  • Raymond LuoDirector
  • Carl Nicholas NgDirector
Offering amount
$3M
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedFeb 2025 · 4 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Raymond LuoDirector
  • Thomas WeindlExecutive Officer, Director
  • Carl Nicholas NgDirector
Offering amount
$1M
Amount sold
$700K
First sale
Feb 2025
Incorporated
Corporation, Delaware, 2021
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does OLI Technologies do?
OLI Technologies develops technology for decentralizing kidney care, working on chemistry, mechanical, and software engineering to support treatment outside centralized clinical settings. The company is developing a medical device, having completed its first animal study.
Who are OLI Technologies's investors?
OLI Technologies's investors include SOSV, Verge HealthTech Fund, BoxOne Ventures.
How much funding has OLI Technologies raised?
OLI Technologies has disclosed $700K raised across 1 of its 2 known rounds.
Where is OLI Technologies headquartered?
OLI Technologies is headquartered in North Brunswick, US.